Table 2.
Cardiac arrhythmias in DNA viruses
| Virus | Author, year, country | Study design | Sample size (n) | Notable arrhythmias | Reported myocarditis (%) |
|---|---|---|---|---|---|
| Adenovirus | Multiple | Case reports | Ventricular arrhythmias | N/A | |
| HHV-6 | Amin 2021, Iran | Case series | 3 |
Mobitz type II AV block (33.3%) VT (33.3%) |
100 |
| Parvovirus B19 | Multiple | Case reports | Ventricular arrhythmias | N/A | |
| HSV | Chiang 2011, Taiwan | Retrospective case–control | 88,377 | AF (1.6% of study vs 1.1% in control) | N/A |
| CMV | Multiple | Case reports | AV block | N/A | |
| EBV | Mavrogeni 2011, Greece | Case series | 6 | VT (100%) | 100 |
| VZV | Cha 2018, South Korea | Retrospective case control | 153,425 | AF (6.4 per 1,000 patient-years) in severe VZV vs (2.6 per 1000 patient-years) in non-VZV group | N/A |
| Park 2022, USA | Meta-analysis of 7 studies | 94,928 | Atrial arrhythmia (6.4 cases per 1000 person years); 35% greater than those without HIV |